Laboratorios Farmaceuticos Rovi SA
(XMAD:ROVI)
€
85.5
0.55 (0.65%)
Market Cap: 4.37 Bil
Enterprise Value: 4.44 Bil
PE Ratio: 32.51
PB Ratio: 8.44
GF Score: 83/100 Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) Transcripts
- Q4 2023 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 27, 2024€67.5 (-5.59%)Earnings
- Q2 2023 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptJul 26, 2023€45.94 (+9.85%)Earnings
- Q4 2022 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 28, 2023€41.7Earnings
- Laboratorios Farmaceuticos ROVI SA Capital Market Day 2022 TranscriptNov 23, 2022
- Q2 2022 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptJul 27, 2022€57.25 (-4.42%)Earnings
- Q4 2021 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 23, 2022€72.4 (+3.43%)Earnings
- Half Year 2021 Laboratorios Farmaceuticos ROVI SA Earnings Presentation TranscriptJul 28, 2021
- Full Year 2020 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 24, 2021€45.5 (-0.44%)Earnings
- Half Year 2020 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptJul 27, 2020€30.6Earnings
- Full Year 2019 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 26, 2020€25.2 (+1.20%)Earnings
- Half Year 2019 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptJul 30, 2019€21.1 (+2.93%)Earnings
- Laboratorios Farmaceuticos Rovi, S.A. - Special Call TranscriptMar 19, 2019
- 1